ADD CONDITION

items per page

Vapor Inhaler

Last content change checked dailysee data sync status

Active ingredient
Levmetamfetamine 50 mg
Dosage form
Inhalant
Route
Nasal
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2021
Label revision date
September 19, 2025
Manufacturer
Geiss, Destin & Dunn, Inc.
Registration number
M012
NDC root
50804-281

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

GOODSENSE® is a nasal decongestant that comes in the form of a vapor inhaler. It contains levmetamfetamine, which helps provide temporary relief from nasal congestion caused by conditions such as the common cold, hay fever, or upper respiratory allergies.

This product is designed to help you breathe more easily when you're experiencing nasal congestion, making it a useful option for alleviating discomfort associated with these common ailments.

Uses

If you're dealing with nasal congestion from the common cold, hay fever, or upper respiratory allergies, this medication can provide you with temporary relief. It helps to clear up your nasal passages, making it easier for you to breathe comfortably.

Rest assured, there are no concerns about teratogenic effects (which means it won't cause birth defects) associated with this medication. This makes it a safer option for those who may be pregnant or planning to become pregnant.

Dosage and Administration

When using this product, you will receive a dose of levmetamfetamine, which is a medication that helps relieve nasal congestion. Each time you use it, you will inhale 800 ml of air that contains between 0.04 to 0.150 mg of levmetamfetamine. For adults and children aged 12 and older, you should take 2 inhalations in each nostril. If you are supervising a child aged 6 to under 12 years, they should take 1 inhalation in each nostril.

It's important to remember that you should not use this medication more often than every 2 hours. If you have a child under 6 years old, consult a doctor before use, and do not use this product for children under 2 years of age. Always follow these guidelines to ensure safe and effective use.

What to Avoid

It's important to use this medication responsibly to ensure your safety and well-being. You should not use it for more than 7 days, and always follow the directions provided. Using it frequently or for an extended period can lead to a return or worsening of nasal congestion. Additionally, make sure not to exceed the recommended dosage, as doing so can pose risks to your health.

Side Effects

You may experience some temporary side effects when using this product, such as burning, stinging, sneezing, or increased nasal discharge. It's important to note that you should not use it for more than 7 days, as frequent or prolonged use can lead to worsening nasal congestion. If your symptoms persist, please stop using the product and consult a doctor.

If you are pregnant or breastfeeding, it's advisable to speak with a healthcare professional before using this product. Additionally, keep it out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

It's important to follow the recommended dosage when using this medication, as exceeding it can lead to unwanted side effects. You may experience temporary burning, stinging, sneezing, or increased nasal discharge. Additionally, sharing this container with others can spread infections, so it's best to keep it for your personal use only.

For your safety, do not use this medication for more than 7 days, and always follow the directions provided. Using it frequently or for an extended period may cause your nasal congestion to come back or worsen. If you accidentally swallow the medication, seek medical help or contact a Poison Control Center immediately. If your symptoms persist, stop using the medication and consult your doctor for further advice.

Overdose

It's important to keep this medication out of reach of children. If a child accidentally swallows it, you should seek medical help immediately or contact a Poison Control Center.

In case of an overdose, you may notice signs such as unusual drowsiness, confusion, or difficulty breathing. If you or someone else experiences these symptoms, it's crucial to get emergency assistance right away. Always prioritize safety and act quickly if an overdose is suspected.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

It's important to be cautious when using this medication for children. If your child is under 2 years old, you should not use this product. For children aged 6 to under 12 years, they can use 1 inhalation in each nostril, but it's essential that an adult supervises them during this process.

If your child is under 6 years old, it's best to consult with a doctor before using this medication. For those aged 12 and older, the recommended dosage is 2 inhalations in each nostril. Always follow these guidelines to ensure the safety and well-being of your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have about taking this medication with your liver condition. They can help ensure that your treatment is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that your overall treatment plan is safe and effective.

Always discuss any other medications, supplements, or health conditions you have, as this information can help your provider make the best decisions for your health.

Storage and Handling

To ensure the best performance of your inhaler, store it in a cool, dry place at temperatures between 59°-86° F (15°-30° C). It's important to keep the inhaler tightly closed when not in use to protect it from moisture and contamination.

Once you start using the inhaler, it remains effective for at least 3 months. Always handle it with care to maintain its integrity and effectiveness.

Additional Information

No further information is available.

FAQ

What is GOODSENSE®?

GOODSENSE® is a nasal decongestant vapor inhaler that contains levmetamfetamine, providing temporary relief of nasal congestion.

What conditions does GOODSENSE® help relieve?

It helps relieve nasal congestion due to the common cold, hay fever, or upper respiratory allergies.

How should I use GOODSENSE®?

Adults and children 12 years and older should take 2 inhalations in each nostril, while children aged 6 to under 12 should take 1 inhalation in each nostril with adult supervision.

Are there any age restrictions for using GOODSENSE®?

Children under 2 years of age should not use this product, and those under 6 years should consult a doctor.

What are the warnings associated with GOODSENSE®?

Do not exceed the recommended dosage, and do not use for more than 7 days. Temporary burning, stinging, sneezing, or increased nasal discharge may occur.

What should I do if symptoms persist?

Stop using GOODSENSE® and ask a doctor if symptoms persist.

Can I use GOODSENSE® if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, consult a health professional before using GOODSENSE®.

What should I do if GOODSENSE® is swallowed?

If swallowed, seek medical help or contact a Poison Control Center immediately.

How should I store GOODSENSE®?

Keep the inhaler tightly closed and store it at temperatures between 59°-86° F (15°-30° C).

How long is GOODSENSE® effective after first use?

The inhaler remains effective for a minimum of 3 months after first use.

Packaging Info

Below are the non-prescription pack sizes of Vapor Inhaler (levmetamfetamine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Vapor Inhaler.
Details

Drug Information (PDF)

This file contains official product information for Vapor Inhaler, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of nasal congestion associated with the common cold, hay fever, or upper respiratory allergies.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product delivers 0.04 to 0.150 mg of levmetamfetamine in each 800 ml of air. For adults and children aged 12 years and older, the recommended dosage is 2 inhalations in each nostril. For children aged 6 to under 12 years, under adult supervision, the dosage is 1 inhalation in each nostril.

It is important to note that the product should not be used more frequently than every 2 hours. For children under 6 years of age, consultation with a healthcare professional is advised prior to use. The product is contraindicated in children under 2 years of age.

Contraindications

Use is contraindicated for periods exceeding 7 days. Frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. It is essential to adhere strictly to the recommended dosage and to use the product only as directed.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this product to ensure patient safety and efficacy.

Warnings It is imperative that the recommended dosage is not exceeded, as doing so may lead to adverse effects. Patients may experience temporary burning, stinging, sneezing, or increased nasal discharge upon application. Additionally, the use of this container by multiple individuals poses a risk of spreading infection.

General Precautions This product should not be used for more than 7 consecutive days. It is essential to adhere strictly to the directions provided. Frequent or prolonged use may result in the recurrence or worsening of nasal congestion, which could complicate the patient's condition.

Emergency Situations In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Monitoring and Follow-Up Patients should be advised to discontinue use and consult a healthcare provider if symptoms persist, as this may indicate the need for further evaluation or alternative treatment options.

Side Effects

Patients using this product may experience temporary adverse reactions, including burning, stinging, sneezing, or increased nasal discharge. These reactions are generally mild and transient.

It is important to note that the product should not be used for more than 7 days, as frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. Patients are advised to discontinue use and consult a healthcare professional if symptoms persist.

For individuals who are pregnant or breastfeeding, it is recommended to seek advice from a health professional prior to use. Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Vapor Inhaler (levmetamfetamine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Vapor Inhaler.
Details

Pediatric Use

Pediatric patients under 2 years of age should not use this medication. For children aged 6 to under 12 years, the recommended dosage is 1 inhalation in each nostril, to be administered under adult supervision. In contrast, adults and children aged 12 years and older may use 2 inhalations in each nostril. For children under 6 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to use. It is important to assess the potential risks and benefits associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management and intervention.

Prompt action is crucial in mitigating potential adverse effects associated with overdosage. The symptoms may vary depending on the specific substance involved; therefore, a thorough assessment and appropriate treatment plan should be initiated based on the clinical presentation and guidance from poison control experts.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the medication for more than 7 days and to use it only as directed. Emphasize that frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. If symptoms persist, patients should be advised to stop use and consult a doctor.

For patients who are pregnant or breastfeeding, it is important to recommend that they consult a health professional before using the medication. Additionally, patients should be cautioned not to exceed the recommended dosage.

Inform patients that temporary side effects such as burning, stinging, sneezing, or increased nasal discharge may occur. Lastly, healthcare providers should highlight that the use of this container by more than one person may increase the risk of spreading infection.

Storage and Handling

The inhaler is supplied in a configuration that ensures its effectiveness for a minimum of three months following the first use. It is essential to keep the inhaler tightly closed when not in use to maintain its integrity and efficacy.

For optimal storage, the inhaler should be kept at a temperature range of 59° to 86° F (15° to 30° C). Proper adherence to these storage conditions is crucial for preserving the product's performance and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Vapor Inhaler, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Vapor Inhaler, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.